An NSF International Company

Industry news

NSF Health Sciences experts bring you the latest news updates from the industry

EMA Concept Papers on revision of EU GMP Annexes 15 & 17

Friday the 30th November 2012

The EMA has published Concept Papers on the revision of EU GMP Annexes 15 & 17. The consultation period for each is until 28 February 2013.

Annex 15 is being revised to take account of ICH Q8, 9 & 10 as well as technological changes since the current version was published in 2001. The QWP published a draft revision of the Note for Guidance (NfG) on Process Validation in March 2012. The Concept Paper states that the text of other regulatory authorities’ guidance on the subject of process validation (e.g. FDA & WHO) will also be considered in the interests of harmonisation. The timeline proposed in the concept paper envisages a draft revision being published in December 2013.

Annex 17 is being revised to take account of ICH Q8, 9, 10 & 11. It is expected that a revised annex will extend the scope of what has previously been called “Parametric Release” to cover all types of medicinal products and the change its name to “Real Time Release”, which will harmonise with the QWP Guideline of Real Time Release Testing (RTRT) that was published in March 2012. Again the timeline proposed in the concept paper envisages a draft revision being published in December 2013.

Quick links

NSF Health Sciences have offices in Kirkbymoorside and Sheffield, UK and Washington and Ann Arbor, USA

A word from NSF Health Sciences

The legislation and guidance that apply to the healthcare industries is forever changing. NSF Health Sciences will provide you with regular updates on what is new and will also provide you with expert interpretation of these changes - what they mean

Peter Gough

© NSF Health Sciences 2015

Registered Office: NSF Health Sciences, The Georgian House, 22/24 West End, Kirkbymoorside, York, UK, YO62 6AF
Registered in England and Wales No: 3432550 | Tel: +44(0)1751 432999 | Fax: +44(0)1751 432450 | Email: [email protected]
US Office: NSF Health Sciences, 2001 Pennsylvania Ave, NW, Suite 950, Washington DC 20006 | Tel: 1-202-822-1850 | Fax: 1-202-822-1859 | Email: [email protected]